Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model
Authors:
- Rebecca RiedlRRRebecca Riedl
- Annika KühnAKAnnika Kühn
- Denise RietzDRDenise Rietz
- Betty HebeckerBHBetty Hebecker
- Karl-Gunther GlowallaKGKarl-Gunther Glowalla
- Lukas K. PeltnerLPLukas K. Peltner
- Paul M. JordanPaul M. Jordan
- Oliver WerzOWOliver Werz
- Stefan LorkowskiStefan Lorkowski
- Cornelia WiegandCWCornelia Wiegand
- Maria WallertMaria Wallert
Open Access
- 1 August 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (15) , 12325
Abstract
In dermatological research, 2,4-dinitrochlorbenzene (DNCB)-induced atopic dermatitis (AD) is a standard model as it displays many disease-associated characteristics of human AD. However, the reproducibility of the model is challenging due to the lack of information regarding the methodology and the description of the phenotype and endotype of the mimicked disease. In this study, a DNCB-induced mouse model was established with a detailed procedure description and classification of the AD human-like skin type. The disease was induced with 1% DNCB in the sensitization phase and repeated applications of 0.3% and 0.5% DNCB in the challenging phase which led to a mild phenotype of AD eczema. Pathophysiological changes of the dorsal skin were measured: thickening of the epidermis and dermis, altered skin barrier proteins, increased TH1 and TH2 cytokine expression, a shift in polyunsaturated fatty acids, increased pro-resolving and inflammatory mediator formation, and dysregulated inflammation-associated gene expression. A link to type I allergy reactions was evaluated by increased mast cell infiltration into the skin accompanied by elevated IgE and histamine levels in plasma. As expected for mild AD, no systemic inflammation was observed. In conclusion, this experimental setup demonstrates many features of a mild human-like extrinsic AD in murine skin.Keywords
Funding Information
- Free State of Thuringia and the European Social Fund (2019 FGR 0095, 512648189)
- German Research Foundation (2019 FGR 0095, 512648189)
- Open Access Publication Fund of the Thueringer Universitaets- und Landesbibliothek Jena (2019 FGR 0095, 512648189)
This publication has 64 references indexed in Scilit:
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cellsBMC Immunology, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic conceptsJournal of Allergy and Clinical Immunology, 2011
- Atopic DermatitisAnnals of Dermatology, 2010
- Animal Models of Atopic DermatitisJournal of Investigative Dermatology, 2009
- Childhood eczema and asthma incidence and persistence: A cohort study from childhood to middle ageJournal of Allergy and Clinical Immunology, 2008
- Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patientsExperimental Dermatology, 2007
- Investigation of Mechanisms Underlying the T-Cell Response to the Hapten 2,4-DinitrochlorobenzeneJournal of Investigative Dermatology, 2007
- Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E2 and leukotriene B4 are present in biologically active concentrationsJournal of Allergy and Clinical Immunology, 1989